Lincotek Medical Company Profile

Background

Overview

Lincotek Medical, headquartered in Trento, Italy, is a global contract manufacturer specializing in integrated supply chain solutions for the medical device industry. The company offers a comprehensive range of services, including device engineering, casting, forging, additive manufacturing, precision machining, coating technologies, electrochemical treatments, and final packaging. With over 1,100 employees across 16 production facilities in Europe, North America, and Asia, Lincotek Medical serves more than 500 original equipment manufacturers (OEMs) worldwide.

Mission and Vision

Lincotek Medical's mission is to provide OEMs with end-to-end solutions that streamline the manufacturing process, reduce lead times, and enhance product quality. The company's vision is to be a trusted partner in the medical device industry, driving innovation and excellence through integrated supply chain solutions.

Primary Area of Focus

The company's primary focus is on orthopedic, trauma, spine, and dental markets, offering tailored solutions that meet the specific needs of these sectors.

Industry Significance

Lincotek Medical holds a significant position in the medical device manufacturing industry, recognized for its comprehensive service offerings and commitment to quality. The company's expertise in additive manufacturing and coating technologies has established it as a leader in providing innovative solutions to OEMs.

Key Strategic Focus

Core Objectives

Integrated Supply Chain Solutions: Offer a seamless manufacturing process from device conception to final packaging, ensuring efficiency and quality.

Innovation and Technology Leadership: Invest in advanced technologies and research and development to provide cutting-edge solutions to OEMs.

Global Expansion: Strengthen global presence through strategic acquisitions and facility expansions to better serve a diverse customer base.

Specific Areas of Specialization

Additive Manufacturing: Pioneering in 3D printing of medical implants since 2006, with over 800,000 implantable devices produced.

Coating Technologies: Specializing in thermal spray coatings, including plasma spray, calcium phosphate, and physical vapor deposition coatings.

Surface Finishing: Expertise in metal surface finishing, including anodizing, electropolishing, passivation, and low friction chrome coating.

Key Technologies Utilized

CAPS Intercooler: A proprietary technology for advanced porous coatings, ensuring high consistency and quality.

Air Plasma Spray (APS): A coating technology that allows for identical coating parameters across different production lines, enhancing flexibility and reducing lead times.

HAnano Surface Technology: An advanced super hydrophilic and bioactive surface treatment for orthopedic implants, improving osseointegration.

Primary Markets Targeted

Orthopedic Devices: Including implants and instruments for joint replacement and trauma applications.

Spine and Dental Devices: Providing specialized solutions for spinal and dental implant manufacturers.

Financials and Funding

Funding History

Lincotek Medical is a privately held, family-owned company. Specific details regarding total funds raised and recent funding rounds are not publicly disclosed.

Notable Investors

As a privately held entity, Lincotek Medical does not have publicly disclosed investors.

Utilization of Capital

The company has strategically invested in expanding its manufacturing capabilities, enhancing technological infrastructure, and pursuing strategic acquisitions to strengthen its market position.

Pipeline Development

Key Pipeline Candidates

Lincotek Medical's pipeline includes the development of advanced coating technologies, additive manufacturing solutions, and surface finishing processes tailored for orthopedic and dental implants.

Stages of Development

Research and Development: Ongoing efforts to innovate and refine manufacturing processes.

Pilot Production: Testing and validation of new technologies and processes.

Full-Scale Manufacturing: Implementation of successful technologies into mainstream production.

Target Conditions

The company's developments aim to address challenges in implant osseointegration, durability, and patient outcomes in orthopedic and dental applications.

Anticipated Milestones

Product Launches: Introduction of new implant designs and coating technologies to the market.

Regulatory Approvals: Achieving necessary certifications and approvals for new products.

Technological Platform and Innovation

Proprietary Technologies

CAPS Intercooler: Ensures high-quality porous coatings for orthopedic implants.

Air Plasma Spray (APS): Allows for consistent coating parameters across different production lines.

HAnano Surface Technology: Enhances implant osseointegration through advanced surface treatments.

Significant Scientific Methods

Additive Manufacturing: Utilizing 3D printing technologies to produce complex implant geometries and customized solutions.

Surface Engineering: Employing advanced coating and finishing techniques to improve implant performance and longevity.

Leadership Team

Key Executives

Winfried Schaller: CEO of Lincotek Group, overseeing global operations and strategic direction.

Gennaro D’Andrea: General Manager of Lincotek Medical Division, responsible for leading the medical division's growth and innovation strategies.

Francesco Buccioti: Head of Global Business and Business Development at Lincotek Medical, focusing on expanding business opportunities and partnerships.

Professional Backgrounds

Winfried Schaller: Brings extensive experience in managing global manufacturing operations and driving strategic initiatives.

Gennaro D’Andrea: Has a strong background in medical device manufacturing and has been instrumental in expanding Lincotek Medical's capabilities.

Francesco Buccioti: Specializes in business development and has played a key role in establishing strategic partnerships and expanding the company's market presence.

Key Contributions

Winfried Schaller: Led the rebranding of Unitedcoatings Group to Lincotek, signaling a new era for the company.

Gennaro D’Andrea: Oversaw the expansion of Lincotek Medical's facilities in Bartlett, Tennessee, enhancing manufacturing capacity.

Francesco Buccioti: Instrumental in the development and commercialization of Lincotek's additive manufacturing solutions.

Leadership Changes

Recent Appointments

Vittorio Tavanti: Appointed as the new Group Chief Financial Officer, also taking on the role of Chief Information Officer to reflect the critical role of technology in Lincotek's success.

Competitor Profile

Market Insights and Dynamics

The medical device manufacturing industry is characterized by rapid technological advancements, stringent regulatory requirements, and a growing demand for personalized and minimally invasive solutions. Companies are increasingly focusing on integrating supply chain processes to enhance efficiency and reduce time to market.

Competitor Analysis

CoorsTek Medical: A significant player in the medical device manufacturing sector, offering a range of implantable devices and components.

Stryker Corporation: A leading medical technology company specializing in orthopedic implants and instruments.

Zimmer Biomet: A global company providing musculoskeletal healthcare products, including orthopedic implants.

Strategic Collaborations and Partnerships

Danco Medical: Acquired a majority stake in February 2022, enhancing Lincotek Medical's capabilities in metal surface finishing.

Promimic: Entered into a strategic license agreement in May 2025 to incorporate HAnano Surface technology into Lincotek's service portfolio.

Operational Insights

Strategic Considerations

Lincotek Medical's integrated supply chain solutions provide a competitive advantage by offering OEMs a streamlined manufacturing process, reducing lead times, and ensuring high-quality standards. The company's focus on innovation and strategic partnerships positions it well to meet the evolving demands of the medical device industry.